{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"6c186e502c3f65e7cfe618c8ba12b61956f433d38c9b5f34fd8de5abddaef68c","attributes":{"feedName":"fda","feedSource":"fda","title":"Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label","description":"Eno Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack to the consumer level. The products have been found to have incorrect daily dosing information on the label due to a labeling error.","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/endo-pharmaceuticals-issues-voluntary-nationwide-recall-two-lots-robaxinr-750mg-tablets-100-count","publicationDate":"2019-05-02T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers"],"categories":["drugs"],"contaminants":[],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"none","token":"5d9e68ca8b079e002a251abb"}}}